NLRP3 and diabetes mellitus: The activated LRR region inhibits NLRP3 inflammasome activation through NEK7-NLRP3 complex with NIMA-related kinase 7 (NEK7), which plays an important role in AS, diabetes, Alzheimer's disease, and inflammatory bowel disease [5].